429 related articles for article (PubMed ID: 29773435)
1. Epidemiology of antifungal susceptibility: Review of literature.
Hadrich I; Ayadi A
J Mycol Med; 2018 Sep; 28(3):574-584. PubMed ID: 29773435
[TBL] [Abstract][Full Text] [Related]
2. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
3. SUSCEPTIBILITY TEST FOR FUNGI: CLINICAL AND LABORATORIAL CORRELATIONS IN MEDICAL MYCOLOGY.
Alastruey-Izquierdo A; Melhem MS; Bonfietti LX; Rodriguez-Tudela JL
Rev Inst Med Trop Sao Paulo; 2015 Sep; 57 Suppl 19(Suppl 19):57-64. PubMed ID: 26465371
[TBL] [Abstract][Full Text] [Related]
4. Current status of antifungal resistance and its impact on clinical practice.
Alcazar-Fuoli L; Mellado E
Br J Haematol; 2014 Aug; 166(4):471-84. PubMed ID: 24749533
[TBL] [Abstract][Full Text] [Related]
5. Update from the Laboratory: Clinical Identification and Susceptibility Testing of Fungi and Trends in Antifungal Resistance.
Albataineh MT; Sutton DA; Fothergill AW; Wiederhold NP
Infect Dis Clin North Am; 2016 Mar; 30(1):13-35. PubMed ID: 26739605
[TBL] [Abstract][Full Text] [Related]
6. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
Jensen RH
Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
[TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibility testing: a primer for clinicians.
Kuper KM; Coyle EA; Wanger A
Pharmacotherapy; 2012 Dec; 32(12):1112-22. PubMed ID: 23165897
[TBL] [Abstract][Full Text] [Related]
8. Antifungal drug resistance: does it matter?
Rogers TR
Int J Infect Dis; 2002 Mar; 6 Suppl 1():S47-53. PubMed ID: 12044289
[TBL] [Abstract][Full Text] [Related]
9. The evolving role of antifungal susceptibility testing.
Eschenauer GA; Carver PL
Pharmacotherapy; 2013 May; 33(5):465-75. PubMed ID: 23553342
[TBL] [Abstract][Full Text] [Related]
10. Antifungal susceptibility testing. New technology and clinical applications.
Pfaller MA; Yu WL
Infect Dis Clin North Am; 2001 Dec; 15(4):1227-61. PubMed ID: 11780273
[TBL] [Abstract][Full Text] [Related]
11. The current role of the reference procedures by CLSI and EUCAST in the detection of resistance to antifungal agents in vitro.
Cuenca-Estrella M; Rodriguez-Tudela JL
Expert Rev Anti Infect Ther; 2010 Mar; 8(3):267-76. PubMed ID: 20192681
[TBL] [Abstract][Full Text] [Related]
12. Role of antifungal susceptibility testing in patient management.
Forrest G
Curr Opin Infect Dis; 2006 Dec; 19(6):538-43. PubMed ID: 17075328
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact.
Kanafani ZA; Perfect JR
Clin Infect Dis; 2008 Jan; 46(1):120-8. PubMed ID: 18171227
[TBL] [Abstract][Full Text] [Related]
14. Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013).
Castanheira M; Messer SA; Rhomberg PR; Pfaller MA
Diagn Microbiol Infect Dis; 2016 Jun; 85(2):200-4. PubMed ID: 27061369
[TBL] [Abstract][Full Text] [Related]
15. [Microbiological procedures for diagnosing mycoses and for antifungal susceptibility testing].
Gadea I; Cuenca-Estrella M; Martín E; Pemán J; Pontón J; Rodríguez-Tudela JL
Enferm Infecc Microbiol Clin; 2007 May; 25(5):336-40. PubMed ID: 17504688
[TBL] [Abstract][Full Text] [Related]
16. Changing epidemiology of systemic fungal infections.
Richardson M; Lass-Flörl C
Clin Microbiol Infect; 2008 May; 14 Suppl 4():5-24. PubMed ID: 18430126
[TBL] [Abstract][Full Text] [Related]
17. Importance of pharmacokinetic considerations for selecting therapy in the treatment of invasive fungal infections.
Lewis RE
Am J Ther; 2012 Jan; 19(1):51-63. PubMed ID: 21248618
[TBL] [Abstract][Full Text] [Related]
18. Breakpoints for posaconazole susceptibility testing: background and discussion about the need of establishing values.
Fleck R; Hof H
Mycoses; 2008 Sep; 51 Suppl 2():1-4. PubMed ID: 18721327
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of in vitro antifungal susceptibility testing.
Espinel-Ingroff A
Rev Esp Quimioter; 2000 Jun; 13(2):161-6. PubMed ID: 10918088
[TBL] [Abstract][Full Text] [Related]
20. [Mycoses].
Yamazumi T; Furuta I
Rinsho Byori; 2002 Sep; 50(9):853-9. PubMed ID: 12386962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
